TickerFacts.

Warby Parker Inc. (WRBY): Capital Expenditures

Annual figures by period end, from SEC filings.

$67.05M
Year ended 2025-12-31
$73.61M
Trailing 12 months to 2026-06-30
+3.7%
3-year compound annual growth
+27.3%
5-year compound annual growth
2019-12-31: $32.63M2020-12-31: $20.07M2021-12-31: $48.51M2022-12-31: $60.18M2023-12-31: $53.67M2024-12-31: $64.03M2025-12-31: $67.05M$67.05M
2019-12-31 Capital Expenditures (USD) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-31$67.05M+4.7%2026-02-26, From 2025-01-01
2024-12-31$64.03M+19.3%2026-02-26, From 2024-01-01
2023-12-31$53.67M-10.8%2026-02-26, From 2023-01-01
2022-12-31$60.18M+24.1%2025-02-27, From 2022-01-01
2021-12-31$48.51M+141.7%2024-02-29, From 2021-01-01
2020-12-31$20.07M-38.5%2023-02-28, From 2020-01-01
2019-12-31$32.63Mn/a2022-03-18, From 2019-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Ophthalmic Goods), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
Warby Parker Inc. (WRBY)2025-12-31$67.05M+4.7%
National Vision Holdings, Inc. (EYE)2026-01-03$72.84M-23.7%
Staar Surgical Co (STAA)2026-01-02$5.82M-75.1%
Cooper Companies, Inc. (COO)2025-10-31$362.40M-14.0%
Bausch & Lomb Corp (BLCO)2025-12-31$349.00M+19.9%
RxSight, Inc. (RXST)2025-12-31$3.83M-29.6%
Innovative Eyewear Inc (LUCY)2025-12-31$72.5K+16.6%

Compare WRBY, EYE, STAA, COO side by side · Screen every company in Ophthalmic Goods ↗